IMR Press / RCM / Volume 23 / Issue 1 / DOI: 10.31083/j.rcm2301019
Open Access Review
Sex beyond cardiovascular risk factors and clinical biomarkers of cardiovascular disease
Show Less
1 Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40138 Bologna, Italy

Academic Editor: Leonardo De Luca

Rev. Cardiovasc. Med. 2022 , 23(1), 1; https://doi.org/10.31083/j.rcm2301019
Submitted: 1 July 2021 | Revised: 4 August 2021 | Accepted: 3 September 2021 | Published: 14 January 2022
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

In recent years, increasing attention has been reserved to the analysis of sex-related differences in pathophysiology and prognosis of ischemic heart disease (IHD). The traditional conventional cardiovascular risk factors (hypertension, hypercholesteremia, diabetes mellitus and cigarette smoking) are still considered the major risk factors for IHD in both sexes. Nevertheless, recent studies show that they may interact with male and female coronary anatomy in a different manner. The path to sex-specific risk stratification of IHD is also supported by differences in inflammation and necrosis biomarkers (such as C-reactive protein and troponins, respectively). Indeed, large cohort studies often show different mean values of these markers in men and women. The current review summarizes the state-of-art knowledge on sex-related differences in cardiovascular risk factors and cardiac biomarkers with a prognostic value.

Keywords
Ischemic heart disease
Sex differences
Women
Biomarkers
Risk factors
Figures
Fig. 1.
Share
Back to top